Coeptis Therapeutics Holdings Inc (ZSQR)

Currency in USD
14.200
+0.120(+0.85%)
Real-time Data·
ZSQR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.79014.400
52 wk Range
6.80021.410
Key Statistics
Prev. Close
14.08
Open
14.16
Day's Range
13.79-14.4
52 wk Range
6.8-21.41
Volume
30.86K
Average Volume (3m)
63.84K
1-Year Change
73.8272%
Book Value / Share
2.54
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZSQR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 19, 2026
EPS / Forecast
-0.29 / --
Revenue / Forecast
862.05K / --
EPS Revisions
Last 90 days

ZSQR Income Statement

Compare ZSQR to Peers and Sector

Metrics to compare
ZSQR
Peers
Sector
Relationship
P/E Ratio
−7.8x0.0x−0.5x
PEG Ratio
−0.160.000.00
Price/Book
6.9x0.0x2.6x
Price / LTM Sales
68.6x0.0x3.3x
Upside (Analyst Target)
-0.0%47.1%
Fair Value Upside
Unlock0.0%6.2%Unlock

As of April 24, 2026, Coeptis Therapeutics Holdings, Inc. was acquired by Z Squared Inc., in a reverse merger transaction. Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company’s product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze cancer patients if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a chimeric antigen receptor (CAR) therapy for treatment for cancer. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson’s Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

People Also Watch

16.198
EUDA
-5.22%
9.968
ERAS
-1.70%
28.01
SIM
0.00%
78.77
IOSP
+2.99%
3.40
BATL
-7.35%

FAQ

What Is the Coeptis Therapeutics Holdings (ZSQR) Stock Price Today?

The Coeptis Therapeutics Holdings stock price today is 14.200 USD.

What Stock Exchange Does Coeptis Therapeutics Holdings Trade On?

Coeptis Therapeutics Holdings is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Coeptis Therapeutics Holdings?

The stock symbol for Coeptis Therapeutics Holdings is "ZSQR."

What Is the Coeptis Therapeutics Holdings Market Cap?

As of today, Coeptis Therapeutics Holdings market cap is 86.440M USD.

What Is Coeptis Therapeutics Holdings's Earnings Per Share (TTM)?

The Coeptis Therapeutics Holdings EPS (TTM) is -2.814.

From a Technical Analysis Perspective, Is ZSQR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Coeptis Therapeutics Holdings Stock Split?

Coeptis Therapeutics Holdings has split 1 times.

How Many Employees Does Coeptis Therapeutics Holdings Have?

Coeptis Therapeutics Holdings has 5 employees.

What is the current trading status of Coeptis Therapeutics Holdings (ZSQR)?

As of May 05, 2026, Coeptis Therapeutics Holdings (ZSQR) is trading at a price of 14.200 USD, with a previous close of 14.080 USD. The stock has fluctuated within a day range of 13.790 USD to 14.400 USD, while its 52-week range spans from 6.800 USD to 21.410 USD.

What Is the ZSQR After Hours Price?

ZSQR's last after hours stock price is 13.887 USD, the stock has decreased by -0.194, or -1.370%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.